Telbivudine versus Entecavir in Patients with Chronic Hepatitis B: 2-Year Results of a Head-To-Head Trial

被引：0
|
作者：
Huang, Jing [1 ]
Chen, Xiaoping [1 ]
Chen, Xuefu [1 ]
Chen, Re [1 ]
Chen, Wenli [1 ]
Ma, Xiaojun [1 ]
Luo, Xiaodan [1 ]
机构：
[1] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
983
引用
收藏
页码：681A / 681A
页数：1
相关论文
共 50 条
  • [41] A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
    Ren, Fen-Yu
    Piao, Dong-Ming
    Piao, Xi-Xu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (31) : 4264 - 4267
  • [42] Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study (vol 388, pg 2763, 2016)
    Smolen, J. S.
    Burmester, G-R
    Combe, B.
    LANCET, 2016, 388 (10061): : 2742 - 2742
  • [43] Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Chronic Hepatitis B Patients: A Randomized Controlled Trial
    Sriprayoon, Tassanee
    Lueangarun, Saoraya
    Suwanwela, Charas
    Pittayapoom-Pattaranutaporn
    Tanwandee, Tawesak
    GASTROENTEROLOGY, 2012, 142 (05) : S695 - S695
  • [44] EFFICACY AND SAFETY OF ENTECAVIR MONOTHERAPY VERSUS STANDARD OF CARE IN CHRONIC HEPATITIS B: 2-YEAR INTERIM SINGLE CENTRE REPORT OF THE REALM STUDY
    Lu, Wei
    Oo, Aung Myat
    Dan, Yock Young
    Lee, Yin-Mei
    Lim, Kieron B.
    Gowans, Michelle
    Low, How Cheng
    Lee, Guan Huei
    Chung, Stephanie
    Lim, Seng Gee
    HEPATOLOGY, 2011, 54 : 1043A - 1044A
  • [45] Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study (vol 388, pg 2763, 2016)
    Smolen, J. S.
    Burmester, G-R
    Combeet, B.
    LANCET, 2017, 389 (10068): : E2 - E2
  • [46] Entecavir maleate versus entecavir in Chinese chronic hepatitis B predominantly genotype B or C: Results at week 144
    Xu, J. -H.
    Wang, S.
    Xu, Z. -N.
    Yu, Y. -Y.
    Si, C. -W.
    Zeng, Z.
    Li, J.
    Mao, Q.
    Zhang, D. -Z.
    Tang, H.
    Sheng, J. -F.
    Chen, X. -Y.
    Ning, Q.
    Shi, G. -F.
    Xie, Q.
    Zhang, X. -Q.
    Dai, J.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (10) : 877 - 884
  • [47] SWITCHING TO ENTECAVIR IN CHRONIC HEPATITIS B PATIENTS WITH INCOMPLETE VIROLOGIC RESPONSE TO TELBIVUDINE - A PROSPECTIVE VALIDATION OF THE ROADMAP APPROACH
    Lo, Angeline Oi-Shan
    Wong, Vincent W.
    Wong, Grace
    Chan, Hoi Yun
    Cheung, Christina
    Chan, Henry Lik-Yuen
    HEPATOLOGY, 2011, 54 : 1051A - 1051A
  • [48] Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy
    Law, Siu-Tong
    Lee, Ming Kai
    Lee, Ann Shing
    Tung, Yuk
    Li, Kin Kong
    JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (05) : 325 - 333
  • [49] Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naive Taiwanese patients with chronic hepatitis B
    Chien, Rong-Nan
    Peng, Cheng-Yuan
    Kao, Jia-Horng
    Hu, Tsung-Hui
    Lin, Chun-Che
    Hu, Chi-Tan
    Chen, Chi-Yi
    Hsieh, Tsai-Yuan
    Lin, Han-Chieh
    Chuang, Wan-Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 185 - 192
  • [50] Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B
    Law, Siu-tong
    Lee, Ming Kai
    Li, Kin Kong
    Mok, Chun Keung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (02) : 193 - 198
12345